The tumor suppressor TP53 can initiate a plethora of anti-proliferative effects to maintain genomic integrity under conditions of genotoxic stress. The N-terminal proline-rich domain (PRD) of TP53 is important in the regulation of TP53 activity and stability. A common polymorphism at codon 72 in this region has been associated with altered cancer risk in humans. The Trp53ΔP mouse, which carries a germline homozygous deletion of a region of the PRD, does not develop spontaneous tumors in a mixed 129/Sv and C57BL/6 genetic background, but is highly susceptible to a broad range of tumor types following total body exposure to 4 Gy gamma (γ) radiation. This contrasts with the tumor spectrum in Trp53 null (-/-) mice, which mainly develop thymic l...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
Loss of p53 function can lead to a variety of cancers, including breast cancer. Mice heterozygous fo...
In mice, genetic modification of the gene encoding p53 affects both cancer incidence and longevity. ...
The tumor suppressor TP53 can initiate a plethora of anti-proliferative effects to maintain genomic ...
The single nucleotide polymorphism (SNP) at codon 72 of the tumor suppressor gene p53 codes for eith...
Ionising radiation (IR) is a recognised carcinogen responsible for cancer development in patients pr...
BACKGROUND: The p53 tumor suppressor gene is mutated in a large percentage of human malignancies, in...
International audienceThe stability and activity of tumor suppressor p53 are tightly regulated and p...
The stability and activity of tumor suppressor p53 are tightly regulated and partially depend on the...
Known as the guardian of the genome, transformation-related protein 53 (TRP53) is a well -known tumo...
TP53 mutations are the most frequent genetic alterations in breast cancer and are associated with mo...
Apoptotic and DNA damage endpoints are frequently used as surrogate markers of cancer risk, and have...
Risk prediction and dose limits for human radiation exposure are based on the assumption that risk i...
The human p53 tumor suppressor gene TP53 is mutated at a high frequency in sporadic breast cancer, a...
Activation of apoptosis is believed to be critical for the role of p53 as a tumor suppressor. Here, ...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
Loss of p53 function can lead to a variety of cancers, including breast cancer. Mice heterozygous fo...
In mice, genetic modification of the gene encoding p53 affects both cancer incidence and longevity. ...
The tumor suppressor TP53 can initiate a plethora of anti-proliferative effects to maintain genomic ...
The single nucleotide polymorphism (SNP) at codon 72 of the tumor suppressor gene p53 codes for eith...
Ionising radiation (IR) is a recognised carcinogen responsible for cancer development in patients pr...
BACKGROUND: The p53 tumor suppressor gene is mutated in a large percentage of human malignancies, in...
International audienceThe stability and activity of tumor suppressor p53 are tightly regulated and p...
The stability and activity of tumor suppressor p53 are tightly regulated and partially depend on the...
Known as the guardian of the genome, transformation-related protein 53 (TRP53) is a well -known tumo...
TP53 mutations are the most frequent genetic alterations in breast cancer and are associated with mo...
Apoptotic and DNA damage endpoints are frequently used as surrogate markers of cancer risk, and have...
Risk prediction and dose limits for human radiation exposure are based on the assumption that risk i...
The human p53 tumor suppressor gene TP53 is mutated at a high frequency in sporadic breast cancer, a...
Activation of apoptosis is believed to be critical for the role of p53 as a tumor suppressor. Here, ...
Mutations in the p53 tumor suppressor gene are found in over 50% of human tumors and in the germline...
Loss of p53 function can lead to a variety of cancers, including breast cancer. Mice heterozygous fo...
In mice, genetic modification of the gene encoding p53 affects both cancer incidence and longevity. ...